Urinary incontinence is one of the most common symptoms of the elderly in aging countries and one of the most common symptoms of urology. As a common clinical disease, urinary incontinence can be caused by mental factors, nervous system diseases, childbirth, trauma, etc. The clinical manifestations are intermittent or continuous urine involuntarily flowing from the urethra. Although urinary incontinence does not cause organic lesions, it seriously affects the patient's quality of life and causes tremendous psychological pressure and affects the normal interaction of patients in society. It is called "social cancer." On the other hand, although the incidence of urinary incontinence is extremely high and the number of elderly people is increasing, the incidence of senile urinary incontinence is increasing relatively. However, its market is characterized by patients’ exposure to “face loss†and lack of understanding. Extremely low, the diagnostic rate is extremely low.
Treatment of urinary incontinence includes non-drug treatment and drug treatment. Non-pharmacological treatment mainly involves self-training of the bladder. This method has a long course of treatment. Patients must have firm perseverance and need to endure physical discomfort for a long time. Drug therapy can quickly relieve symptoms and adjust the patient's body and mind. Therefore, the treatment of urinary incontinence is mainly based on drug therapy.
In terms of anti-incontinence drugs, although traditional anti-acetylcholine drugs have good curative effects and are widely used, serious side effects often make patients repulsive, patients often cannot tolerate, and naturally it is impossible to take long-term medications. Famasia (now Pfizer) successfully pushed Tolterodine onto the market for the characteristics of the market. Tolterodine's clinical trials have shown a therapeutic effect on urinary frequency and urge urinary incontinence, but only moderate and mild side effects, mainly dry mouth, indigestion, dry eyes, headache and constipation. Although tolterodine's adverse reactions were milder, it still caused a large proportion of female patients to withdraw from treatment.
At present, the research and development of anti-incontinence drugs has attracted the attention of the pharmaceutical circles around the world. In recent years, with the continuous in-depth study of the psychiatry, physiology, biochemistry, pharmacology and other aspects of urinary incontinence, the development of related drugs has been continuously achieved. Progress, competition is surging. Tolterodine has been strongly impacted by Vesicare (Solifenacin succinate) of Yamanouchi and Enablex (darifenacin) of Novartis.
The key to the treatment of urinary incontinence drugs is good curative effect, low toxic and side effects, and a wider range of options. Tolterodine is mainly synthesized from cinnamic acid as the main raw material. Research and development experts said that cinnamic acid itself is a spice raw material, without any toxic side effects on the human body. The side effects of tolterodine are mainly due to other compatible ingredients. Through further research on the formulation, it is entirely possible to develop an improved new drug with extremely low side effects, and gram of “social cancer†incontinence for the benefit of patients.
Treatment of urinary incontinence includes non-drug treatment and drug treatment. Non-pharmacological treatment mainly involves self-training of the bladder. This method has a long course of treatment. Patients must have firm perseverance and need to endure physical discomfort for a long time. Drug therapy can quickly relieve symptoms and adjust the patient's body and mind. Therefore, the treatment of urinary incontinence is mainly based on drug therapy.
In terms of anti-incontinence drugs, although traditional anti-acetylcholine drugs have good curative effects and are widely used, serious side effects often make patients repulsive, patients often cannot tolerate, and naturally it is impossible to take long-term medications. Famasia (now Pfizer) successfully pushed Tolterodine onto the market for the characteristics of the market. Tolterodine's clinical trials have shown a therapeutic effect on urinary frequency and urge urinary incontinence, but only moderate and mild side effects, mainly dry mouth, indigestion, dry eyes, headache and constipation. Although tolterodine's adverse reactions were milder, it still caused a large proportion of female patients to withdraw from treatment.
At present, the research and development of anti-incontinence drugs has attracted the attention of the pharmaceutical circles around the world. In recent years, with the continuous in-depth study of the psychiatry, physiology, biochemistry, pharmacology and other aspects of urinary incontinence, the development of related drugs has been continuously achieved. Progress, competition is surging. Tolterodine has been strongly impacted by Vesicare (Solifenacin succinate) of Yamanouchi and Enablex (darifenacin) of Novartis.
The key to the treatment of urinary incontinence drugs is good curative effect, low toxic and side effects, and a wider range of options. Tolterodine is mainly synthesized from cinnamic acid as the main raw material. Research and development experts said that cinnamic acid itself is a spice raw material, without any toxic side effects on the human body. The side effects of tolterodine are mainly due to other compatible ingredients. Through further research on the formulation, it is entirely possible to develop an improved new drug with extremely low side effects, and gram of “social cancer†incontinence for the benefit of patients.
Dental Side Cabinet Create a stylish and efficient dental practice with cabinetry, carts and other furnishings from Esco Medical. Our selection of affordable dental cabinets includes a wide variety of styles, sizes and designs, including rear treatment consoles, sterilization centers and This allows you to find the best cabinetry to suit your office space while also creating a consistent style for your practice. Whether you need extra storage for all your dental supplies or dental carts that allow you to move essential tools from room to room, we`ve got you covered with this Dental Cabinet collection at Esco Medical.
China Dental Side Cabinet,Clinic Cabinet,Dental Furniture,Clinic Furniture, we offered that you can trust. Welcome to do business with us.
Suzhou Escomedical Equipment Co.,Ltd , https://www.escodental.com